StockTipsArenaBeta

BUY Alkem Laboratories Limited — IDBI Capital

BUYAlkem Laboratories Limited
Alkem Laboratories share price target & all analyst calls

byIDBI CapitalHorizon: NA (inferred Swing (≤2wk))6 Nov 2026via IDBI Capital Research Calls Telegram

Entry₹5,250Stated
Target₹5,460
Total upside +4.00%
Stop loss₹5,145-2.00% risk
CMP₹5,2971d ago
Active+0.90%+3.08%upside left 13d left
Follow IDBI Capital for new calls(29% target hit, 425 closed calls)Get alertsWatch ALKEM for new buy/sell callsGet alertsSee 203 other Swing picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 7 Nov, 5:25 pm IST
3 supporting1 neutral1 opposing
Supports the BUY call (3)

MACD above its signal line — bullish momentum

Technicals · macd·7 Nov · today

Alkem Laboratories has appointed Dr. Amrut Naik as the new Chief Executive Officer (CEO) and Key Managerial Personnel.

BSE · Company Update·3 Nov · 4d ago

(opens in new tab)

The US FDA concluded an inspection of Alkem Laboratories' API manufacturing facility in Mandva with no Form 483 observations.

BSE · Company Update·30 Oct · 1w ago

(opens in new tab)
Neutral / worth noting (1)

Q2 FY27 results scheduled — board meets 12 Nov 2026

BSE · Board Meeting·In 5 days

(opens in new tab)
Weighs against the BUY call (1)

RSI at 71 — overbought territory

Technicals · rsi·7 Nov · today

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Alkem Laboratories

All analyst calls on Alkem Laboratories

More from IDBI Capital

Every call and its outcome